Gemphire Therapeutics
Why Robinhood?
You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
GEMP Key Statistics
Stock Snapshot
The current Gemphire Therapeutics(GEMP) stock price is $8.18, with a market capitalization of 18.89M. The stock trades at a price-to-earnings (P/E) ratio of -0.16.
Gemphire Therapeutics(GEMP) stock opened on 2026-05-01 at —. The price climbed to — and dipped to —.
Gemphire Therapeutics(GEMP) shares are trading with a volume of 0, against a daily average of 152.25K.
In the last year, Gemphire Therapeutics(GEMP) shares hit a 52-week high of $19.03 and a 52-week low of $1.17.
In the last year, Gemphire Therapeutics(GEMP) shares hit a 52-week high of $19.03 and a 52-week low of $1.17.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.